FDA Device Intelligence
HomeLEICA BIOSYSTEMS NEWCASTLE LTD › BOND ORACLE HER2 IHC System

BOND ORACLE HER2 IHC System

LEICA BIOSYSTEMS NEWCASTLE LTD · Model TA9145 · UDI-DI 05055331301291

MVC
0
510(k) clearances
21
Adverse events
8
Recalls
7
Facilities

Description

Bond Oracle HER2 IHC System is a semi quantitative immunohistochemical assay to determine HER2 oncoprotein status in breast cancer in breast tissue processed for histological evaluation.

Recalls

DateFirmReason
2014-07-01Biogenex Laboratories, Inc.Product was distributed without 510(k) approval.
2009-09-17Ventana Medical Systems IncIncorrect result: Light staining inconsistencies with lot number 680957 of the Ventana PATHWAY HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody.
2006-02-09Biogenex LaboratoriesProducts produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
2006-02-09Biogenex LaboratoriesProducts produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
2006-02-09Biogenex LaboratoriesProducts produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
2006-02-09Biogenex LaboratoriesProducts produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
2005-09-29Dakocytomation California IncFormulation error in the Visualization Reagent (vial 3) component contained in Hercep Test kits. The error was in the concentration of Polyethylene Glycol contained in the formula
2005-09-29Dakocytomation California IncFormulation error in the Visualization Reagent (vial 3) component contained in Hercep Test kits. The error was in the concentration of Polyethylene Glycol contained in the formula

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.